Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | 10%+ Owner | Common Stock | 1.46M | $43.8M | $30.05 | Mar 1, 2024 | Direct |
Dyne Therapeutics, Inc. | 10%+ Owner | Common Stock | 847K | $25.5M | $30.05 | Mar 1, 2024 | Indirect |
Day One Biopharmaceuticals, Inc. | 10%+ Owner | Common Stock | 793K | $9.27M | $11.69 | Jul 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | Mar 1, 2024 | 2 | -$1.4M | 4 | Mar 5, 2024 | 10%+ Owner |
DAWN | Day One Biopharmaceuticals, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | 10%+ Owner |